406 related articles for article (PubMed ID: 26369382)
21. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
22. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
23. Co-variables in first trimester maternal serum screening.
de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
[TBL] [Abstract][Full Text] [Related]
24. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
25. Influence of maternal age and weight on second-trimester serum alpha-fetoprotein, total and free beta human chorionic gonadotropin levels.
Hsu JJ; Hsieh TT; Soong YK
Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):181-6. PubMed ID: 9397608
[TBL] [Abstract][Full Text] [Related]
26. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
27. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
28. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
[TBL] [Abstract][Full Text] [Related]
29. Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
Berezowsky A; Pardo J; Ben-Zion M; Wiznitzer A; Aviram A
Fetal Diagn Ther; 2019; 46(3):187-192. PubMed ID: 30726846
[TBL] [Abstract][Full Text] [Related]
30. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
31. [Abnormal second trimester screening for fetal chromosomal abnormalities as a predictor of adverse pregnancy outcome].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2007 Nov; 78(11):877-80. PubMed ID: 18306921
[TBL] [Abstract][Full Text] [Related]
32. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.
Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U
Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325
[TBL] [Abstract][Full Text] [Related]
33. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
34. Detection of fetal Turner syndrome with multiple-marker screening.
Wenstrom KD; Williamson RA; Grant SS
Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569
[TBL] [Abstract][Full Text] [Related]
35. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM
Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
[TBL] [Abstract][Full Text] [Related]
36. Biochemical markers of trisomy 21 in amniotic fluid.
Spencer K; Muller F; Aitken DA
Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
[TBL] [Abstract][Full Text] [Related]
37. Multiple marker second trimester serum screening for pre-eclampsia.
Wald NJ; Morris JK
J Med Screen; 2001; 8(2):65-8. PubMed ID: 11480445
[TBL] [Abstract][Full Text] [Related]
38. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
39. Maternal serum screening of fetal chromosomal abnormalities by AFP, UE3, hCG and free-beta hCG. Prospective and retrospective results.
Valerio D; Aiello R; Altieri V; Fagnoni P
Minerva Ginecol; 1996 May; 48(5):169-73. PubMed ID: 8783867
[TBL] [Abstract][Full Text] [Related]
40. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
